Redwire Corp (RDW) said Monday it has expanded its in-space drug development program by launching a new drug development technology and a cancer-detection experiment to the International Space Station.
The company launched an industrial crystallizer to process more enhanced samples that could be previously processed in the original PIL-BOX technology, Redwire added.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。